Oncology
🇪🇺 EMA Page 2EMA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Global oncology market intelligence for pharma BD, investors, and analysts. Track drug approvals, clinical trials, and competitive landscapes.
Showing 13–24 of 94 articles
Medscape's AI Integration in Hematology: A Catalyst for Change at EHA 2026
Datroway Priority Review Fuels Hope for Metastatic Triple-Negative Breast Cancer Patients
ASCO 2026: European Pharma's Quiet Showing and What AstraZeneca & Roche Must Address
ESMO 2025: Key Advances in Non-Muscle-Invasive Bladder Cancer Shape Future Oncology Strategies
Datroway and Trodelvy Vie for First-Line TNBC Dominance Amidst Evolving Treatment Landscape
International School of Clinical Oncology Annual Congress 2026: Key Insights
Imfinzi Receives FDA Approval for Bladder Cancer Treatment
ESMO 2025 Preview: Astra and Daiichi vs. Gilead
Imfinzi Approved for Unique Bladder Cancer Combo: A Game Changer
Camizestrant Recommended for Approval in the EU for Advanced ER-Positive Breast Cancer
SERD Therapy Shows Strong Anti-Proliferative Activity in ER+/HER2- Breast Cancer
ESMO Breast Cancer Congress 2026: Key Insights for Investors